Professional Documents
Culture Documents
OBJECTIVES:
1. Distinguish the general mechanisms in which drugs can affect the functions of the
gastrointestinal system.
2. Determine the indications, contraindications, mechanisms of action, pharmacokinetics, and
side effects of major drug classifications of:
2.1.Drugs that Control Gastric Acidity and Secretion
2.2.Antidiarrheal Agents
2.3.Laxatives and Cathartics
2.4.Miscellaneous Gastrointestinal Drugs
3. Discuss how each drug class in this topic affect the physical therapy management (scheduling
of treatment, monitoring and documentation procedures, applications and/or modifications,
and referral to other medical professionals) of:
3.1.General physical therapy patients and clients
3.2.Patients with acute, subacute, or chronic pain with varying pain intensities
3.3.Patients with Gastrointestinal Irritation, Dyspepsia, Increased Intragastric pH, Peptic
Ulcer, Gastroesophageal Reflux Disorder, Gastrointestinal Hypermotility and Hypomotility,
Nausea and Vomiting, Indigestion, Stress Ulceration Syndrome, Prolonged Bed Rest
Post-operatively and due to SCI
GENERAL INSTRUCTIONS: Read the questions and instructions carefully. Answers should be
placed in the corresponding space provided. Cite all the sources that were used to complete this
worksheet using the AMA format. A dedicated space for sources can be found at the end of this
worksheet.
I. Fill in the Blanks: Supply the missing word/s in each item. Answers must be completely
written out. Incorrect spelling and the use of abbreviations will be marked wrong. (233 points)
1 of 12
VELEZ COLLEGE
College of Occupational and Physical Therapy
Department of Physical Therapy
2nd Semester, S.Y. 2022-2023
PHARMA – Pharmacology in Rehabilitation
2 of 12
VELEZ COLLEGE
College of Occupational and Physical Therapy
Department of Physical Therapy
2nd Semester, S.Y. 2022-2023
PHARMA – Pharmacology in Rehabilitation
without
activating these
receptors.
These drugs
prevent the
histamine-
activated
release of
gastric acid
under basal
conditions and
during
stimulation by
food, and they
can help
decrease
damage from
gastric acid
caused by
NSAIDs and
other factors
that increase
acid secretion
Proton Pump 1. Esophagitis, Inhibit the H+ , Potential Increased
Inhibitors Dexlansoprazol peptic ulcer K+ -ATPase problems secretion of
e disease, non- enzyme that is include an gastric rebound
2. erosive reflux ultimately increased risk and gastric
Esomeprazole
responsible for of certain polyps
3.
Lansoprazole secreting acid infections
4. Omeprazole from gastric (Clostridium
5. parietal cells difficile,
Pantoprazole into the lumen pneumonia),
of the stomach. decreased
Otherwise absorption of
known as certain
proton pump nutrients
inhibitors have (vitamin B,
antibacterial magnesium,
effects against iron), and
H. pylori kidney
infection and problems such
that they may as interstitial
have some anti- nephritis
3 of 12
VELEZ COLLEGE
College of Occupational and Physical Therapy
Department of Physical Therapy
2nd Semester, S.Y. 2022-2023
PHARMA – Pharmacology in Rehabilitation
inflammatory
properties that
help decrease
gastric
irritation.
Others 1. Anticholiner Gastric acidity 1. Cholinergic 1. Cause Increased risk
gics and mucosal stimulation many side in drug toxicity
2. Metoclopra breakdown of the gut effects, therefore
mide via vagal such as dry worsens side
3. Prostagland
efferent mouth, effects and
ins
4. Sucralfate fibers constipatio condition
produces a n, urinary
general retention,
increase in and
GI motility confusion.
and 2. Restlessnes
secretion. s,
Drugs that drowsiness,
block the and fatigue
effects of are fairly
acetylcholi common in
ne on taking
stomach metoclopra
parietal mide
cells will 3. Prostagland
decrease in analogs
the release may be
of gastric effective
acid. only at
2. Metoclopra doses that
mide cause other
stimulates GI effects,
motility in such as
the upper diarrhea.
GI tract 4. Sucralfate
(prokinetic is well
effect), thus tolerated,
decreasing although
the risk of constipatio
gastric acid n may
moving occur in
backward some
patients.
4 of 12
VELEZ COLLEGE
College of Occupational and Physical Therapy
Department of Physical Therapy
2nd Semester, S.Y. 2022-2023
PHARMA – Pharmacology in Rehabilitation
into the
esophagus.
3. Prostagland
ins such as
PGE2 and
PGI2
inhibit
gastric
secretion
and help
protect the
stomach
mucosa by
stimulating
gastric
mucus
secretion.
4. Sucralfate
is a
disaccharid
e that exerts
a
cytoprotecti
ve effect on
the stomach
mucosa.7
And it may
form a
protective
gel within
the stomach
that adheres
to ulcers
and shields
them from
the contents
of the
stomach.
5 of 12
VELEZ COLLEGE
College of Occupational and Physical Therapy
Department of Physical Therapy
2nd Semester, S.Y. 2022-2023
PHARMA – Pharmacology in Rehabilitation
6 of 12
VELEZ COLLEGE
College of Occupational and Physical Therapy
Department of Physical Therapy
2nd Semester, S.Y. 2022-2023
PHARMA – Pharmacology in Rehabilitation
7 of 12
VELEZ COLLEGE
College of Occupational and Physical Therapy
Department of Physical Therapy
2nd Semester, S.Y. 2022-2023
PHARMA – Pharmacology in Rehabilitation
into the GI
tract.
3. These are
drugs that
sequester
and bind
bile acids
within the
GI tract and
can be
useful in
treating
diarrhea
caused by
excess bile
acid
secretion.
8 of 12
VELEZ COLLEGE
College of Occupational and Physical Therapy
Department of Physical Therapy
2nd Semester, S.Y. 2022-2023
PHARMA – Pharmacology in Rehabilitation
9 of 12
VELEZ COLLEGE
College of Occupational and Physical Therapy
Department of Physical Therapy
2nd Semester, S.Y. 2022-2023
PHARMA – Pharmacology in Rehabilitation
the increased
stool size.
10 of 12
VELEZ COLLEGE
College of Occupational and Physical Therapy
Department of Physical Therapy
2nd Semester, S.Y. 2022-2023
PHARMA – Pharmacology in Rehabilitation
11 of 12
VELEZ COLLEGE
College of Occupational and Physical Therapy
Department of Physical Therapy
2nd Semester, S.Y. 2022-2023
PHARMA – Pharmacology in Rehabilitation
References:
• Bismuth Subsalicylate: Generic, Uses, Side Effects, Dosages, Interactions, Warnings.
(2021, September 2). RxList.
https://www.rxlist.com/consumer_bismuth_subsalicylate_kaopectate/drugs-
condition.html
• Ciccone, C.D. (2016). Pharmacology in rehabilitation (5th ed.). Philadelphia: F.A. Davis
Co.
12 of 12